Does the introduction of an infliximab biosimilar always result in savings for hospitals? A descriptive study using real-world data
Article in Health Economics Review (April 2024)
The most recent citing publications are shown below. View all 86 publications that cite this research output on Dimensions.
Article in Health Economics Review (April 2024)
Article in Regulatory Toxicology and Pharmacology (April 2024)
Book chapter (January 2024)